Alerts will be sent to your verified email
Verify Email
SHUKRAPHAR
|
Shukra Pharma
|
Wanbury
|
Anuh Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
11.12 % | -30.56 % | 15.87 % |
|
5yr average Equity Multiplier
|
2.18 | -3.1 | 1.62 |
|
5yr Average Asset Turnover Ratio
|
0.6 | 1.51 | 1.35 |
|
5yr Avg Net Profit Margin
|
7.6 % | 7.58 % | 7.23 % |
|
Price to Book
|
14.42 | 14.96 | 2.94 |
|
P/E
|
94.63 | 29.05 | 20.25 |
|
5yr Avg Cash Conversion Cycle
|
-20.3 Days | -119.82 Days | 42.81 Days |
|
Inventory Days
|
31.54 Days | 20.62 Days | 50.87 Days |
|
Days Receivable
|
133.87 Days | 49.78 Days | 111.12 Days |
|
Days Payable
|
381.54 Days | 205.91 Days | 117.6 Days |
|
5yr Average Interest Coverage Ratio
|
36.02 | 2.36 | 48.66 |
|
5yr Avg ROCE
|
10.67 % | -51.74 % | 21.17 % |
|
5yr Avg Operating Profit Margin
|
15.03 % | 4.22 % | 10.21 % |
|
5 yr average Debt to Equity
|
0.32 | -0.61 | 0.02 |
|
5yr CAGR Net Profit
|
241.36 % | -2.79 % | 10.73 % |
|
5yr Average Return on Assets
|
6.5 % | 11.1 % | 9.84 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
50.96 % | 39.63 % | 69.92 % |
|
Share Pledged by Promoters
|
0.0 | 76.74 % | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
1.79 % | -0.22 % | -0.67 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Shukra Pharma
|
Wanbury
|
Anuh Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|